Hilde Hermansen Steineger
Gründer bei NorthSea Therapeutics BV
Aktive Positionen von Hilde Hermansen Steineger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Direktor/Vorstandsmitglied | - | - |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Geschäftsführer | 01.12.2017 | - |
Gründer | 01.12.2017 | - |
Karriereverlauf von Hilde Hermansen Steineger
Ehemalige bekannte Positionen von Hilde Hermansen Steineger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THOR MEDICAL | Direktor/Vorstandsmitglied | 01.11.2014 | 28.04.2021 |
Independent Dir/Board Member | 01.11.2014 | 28.04.2021 | |
STRONGBRIDGE BIOPHARMA | Direktor/Vorstandsmitglied | 01.01.2013 | 01.01.2021 |
Independent Dir/Board Member | 01.01.2013 | 01.01.2021 | |
PCI BIOTECH HOLDING ASA | Direktor/Vorstandsmitglied | 13.05.2014 | 01.05.2019 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Public Communications Contact | 08.06.2010 | 23.03.2011 |
Corporate Officer/Principal | 23.03.2011 | 01.05.2015 | |
WEIFA ASA | Direktor/Vorstandsmitglied | 01.01.2007 | 21.05.2013 |
Independent Dir/Board Member | 01.01.2007 | 21.05.2013 | |
ARCTICZYMES TECHNOLOGIES ASA | Direktor/Vorstandsmitglied | 01.01.2005 | 01.01.2007 |
Nordea Bank ABP (Broker)
Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Nordea Bank ABP (Broker) (Nordea Bank-Broker) is the Sweden-based broker/dealer division of Nordea Bank ABP (HEL: NDA-FI; OTCMKTS: NRDBY) in Finland. Headquartered in Stockholm, Nordea Bank-Broker was founded in 2001 and provides trading and execution services to various types of investors. | Analyst-Equity | 10.07.2003 | 10.07.2003 |
░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - | |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Hilde Hermansen Steineger
University of Oslo | Doctorate Degree |
Statistik
International
Norwegen | 16 |
Schweden | 4 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 16 |
Independent Dir/Board Member | 5 |
Corporate Officer/Principal | 4 |
Sektoral
Health Technology | 12 |
Finance | 5 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BASF SE | Producer Manufacturing |
PCI BIOTECH HOLDING ASA | Health Technology |
ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
Private Unternehmen | 20 |
---|---|
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Commercial Services |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
Nordea Securities AB
Nordea Securities AB Investment Banks/BrokersFinance Part of Nordea Bank Abp, Nordea Securities AB is a Swedish company that provides securities brokerage services. The company is based in Stockholm, Sweden. | Finance |
Weifa ASA
Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Neomed Management AS
Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Finance |
Weifa AS
Weifa AS Pharmaceuticals: MajorHealth Technology Weifa AS operates as a pharmaceutical company. The firm supplies non-prescription, over the counter medicines, and lifestyle products. It offers medicines for pain, fever, muscle and joint, colds, wound, as well as vitamins, minerals, and prescription products. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Nordea Bank ABP (Broker)
Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Nordea Bank ABP (Broker) (Nordea Bank-Broker) is the Sweden-based broker/dealer division of Nordea Bank ABP (HEL: NDA-FI; OTCMKTS: NRDBY) in Finland. Headquartered in Stockholm, Nordea Bank-Broker was founded in 2001 and provides trading and execution services to various types of investors. | Finance |
Alertis Medical AS
Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Distribution Services |
Padtech AS
Padtech AS Industrial SpecialtiesProcess Industries Padtech AS manufactures packaging products. The company was founded in 2002 and is headquartered in Fornebu, Norway. | Process Industries |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Invent 2 AS | |
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
PCI Biotech AS
PCI Biotech AS BiotechnologyHealth Technology Part of PCI Biotech Holding ASA, PCI Biotech AS is a Norwegian company that engages in research and development in biotechnology. The company is based in Lysaker, Norway. | Health Technology |
Staten Biotechnology BV
Staten Biotechnology BV BiotechnologyHealth Technology Staten Biotechnology BV develops drugs for the treatment of dyslipidemia. The company was founded by Paul da Silva Jardine, Daniel Rader and Alan Tall in 2014 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Health Technology |
Forbion European Acquisition Corp.
Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
Biotech Pharmacon ASA | |
Alertis AS | |
Afiew AS | |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |